Karuna Therapeutics, Inc.: common_shares_outstanding

Value{"unit": "shares", "value": 26787816, "concept": "us-gaap:CommonStockSharesOutstanding"}
Period (as of 2020-09-30)
Statuscurrent
EntityKaruna Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-20-050820 · Open the official SEC filing →
Retrieved: 2026-08-19T17:58:31.608088+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001771917/common-shares-outstanding/2020-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/ed061822-fe7a-4705-aa8a-9110f84fccd6

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies